In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist

In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist

Item
http://www.wikidata.org/entity/Q28345556
Identification and characterisation of GPR100 as a novel human G-protein-coupled bradykinin receptorCross talk between beta-adrenergic and bradykinin B(2) receptors results in cooperative regulation of cyclic AMP accumulation and mitogen-activated protein kinase activity.Is the Canonical RAF/MEK/ERK Signaling Pathway a Therapeutic Target in SCLC?Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptorsSolitary painful osseous metastases: correlation of imaging features with pain palliation after radiofrequency ablation--a multicenter american college of radiology imaging network study.The kinin system--bradykinin: biological effects and clinical implications. Multiple role of the kinin system--bradykininKinin receptors as targets for cancer therapy.Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway.Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivoExploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.Neuronal differentiation of P19 embryonal carcinoma cells modulates kinin B2 receptor gene expression and function.Bradykinin B2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology.Changes in amino-terminal portion of human B2 receptor selectively increase efficacy of synthetic ligand HOE 140 but not of cognate ligand bradykinin.The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism.Fate of bradykinin on the rat liver when administered by the venous or arterial route.Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer.
P2860

In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist

Item
http://www.wikidata.org/entity/Q28345556
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
In various tumour cell lines t ...... , may act as mitogenic agonist
@ast
In various tumour cell lines t ...... , may act as mitogenic agonist
@en
In various tumour cell lines t ...... , may act as mitogenic agonist
@nl
type
label
In various tumour cell lines t ...... , may act as mitogenic agonist
@ast
In various tumour cell lines t ...... , may act as mitogenic agonist
@en
In various tumour cell lines t ...... , may act as mitogenic agonist
@nl
prefLabel
In various tumour cell lines t ...... , may act as mitogenic agonist
@ast
In various tumour cell lines t ...... , may act as mitogenic agonist
@en
In various tumour cell lines t ...... , may act as mitogenic agonist
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
In various tumour cell lines t ...... , may act as mitogenic agonist
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932